Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes

References

• Fung J, Lai CL, Yuen MF. Hepatitis B and C virus-related carcinogenesis. Clin Microbiol Infect. 2009;15:964–970.
   PubMed Web of Science ®Google Scholar
• Magnussen A, Parsi MA. Aflatoxins, hepatocellular carcinoma and public health. World J Gastroenterol. 2013;19:1508–1512.
   PubMed Web of Science ®Google Scholar
• Wang CH, Wey KC, Mo LR, et al. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma. Asian Pac J Cancer Prev. 2015;16:3595–3604.
   PubMedGoogle Scholar
• Wong VW, Chan HL. Prevention of hepatocellular carcinoma: a concise review of contemporary issues. Ann Hepatol. 2012;11:284–293.
   PubMed Web of Science ®Google Scholar
• Li S, Qian J, Yang Y, et al. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet. 2012;8:e1002791
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer. 2013;13:123–135.
   PubMed Web of Science ®Google Scholar
• Takamizawa A, Mori C, Fuke I, et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 1991;65:1105–1113.
   PubMed Web of Science ®Google Scholar
• Bonilla Guerrero R, Roberts LR. The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J Hepatol. 2005;42:760–777.
   PubMed Web of Science ®Google Scholar
• Goossens N, Hoshida Y. Hepatitis C virus-induced hepatocellular carcinoma. Clin Mol Hepatol. 2015;21:105–114.
   PubMedGoogle Scholar
• Hohler T, Gerken G, Notghi A, et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol. 1997;26: 503–507.
   PubMed Web of Science ®Google Scholar
• Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol. 2003;9:641–644.
   PubMed Web of Science ®Google Scholar
• Zaltron S, Spinetti A, Biasi L, et al. Chronic HCV infection: epidemiological and clinical relevance. BMC Infect Dis. 2012;12:S2.
   Google Scholar
• Ku CS, Loy EY, Pawitan Y, et al. The pursuit of genome-wide association studies: where are we now?. J. Hum. Genet. 2010;55:195–206.
   PubMed Web of Science ®Google Scholar
• Kilpinen H, Dermitzakis ET. Genetic and epigenetic contribution to complex traits. Hum Mol Genet. 2012;21:R24–R28.
   Web of Science ®Google Scholar
• Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385–389.
   PubMed Web of Science ®Google Scholar
• Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci USA. 2009;106:19096–19101.
   PubMed Web of Science ®Google Scholar
• Zhang HX, Zhai Y, Hu ZB, et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet. 2010;42:755–758.
   PubMed Web of Science ®Google Scholar
• de Groot J, Sontheimer H. Glutamate and the biology of gliomas. Glia. 2011;59:1181–1189.
   PubMed Web of Science ®Google Scholar
• Jiang DK, Sun J, Cao G, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet. 2013;45:72–75.
   PubMed Web of Science ®Google Scholar
• Kumar V, Kato N, Urabe Y, et al. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet. 2011;43:455–458.
   PubMed Web of Science ®Google Scholar
• Hirokawa N, Noda Y, Tanaka Y, et al. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol. 2009;10:682–696.
   PubMed Web of Science ®Google Scholar
• Munirajan AK, Ando K, Mukai A, et al. KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J Biol Chem. 2008;283:24426–24434.
   PubMed Web of Science ®Google Scholar
• Yang SZ, Wang JT, Yu WW, et al. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis. World J Gastroenterol. 2015;21:8418–8424.
   PubMed Web of Science ®Google Scholar
• Zhong R, Tian Y, Liu L, et al. HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B. PloS One. 2012;7:e28839. e28839
   Google Scholar
• Sawai H, Nishida N, Mbarek H, et al. No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. BMC Med Genet.2012;13:47
   PubMed Web of Science ®Google Scholar
• Sopipong W, Tangkijvanich P, Payungporn S, et al. The KIF1B (rs17401966) single nucleotide polymorphism is not associated with the development of HBV-related hepatocellular carcinoma in Thai patients. APJCP. 2013;14:2865–2869.
   Google Scholar
• Al-Qahtani A, Al-Anazi M, Viswan NA, et al. Role of single nucleotide polymorphisms of KIF1B gene in HBV-associated viral hepatitis. PloS One. 2012;7:e45128.
   Google Scholar
• Huang M, Pan Y, Liu J, et al. A genetic variant at KIF1B predicts clinical outcome of HBV-related hepatocellular carcinoma in Chinese. Cancer Epidemiol. 2014;38:608–612.
   PubMed Web of Science ®Google Scholar
• Klein J, Sato A. Birth of the major histocompatibility complex. Scand J Immunol. 1998;47:199–209.
   PubMed Web of Science ®Google Scholar
• Klein J, Sato A. The HLA system. First of two parts. N Engl J Med. 2000;343:702–709.
   PubMed Web of Science ®Google Scholar
• Donaldson PT, Ho S, Williams R, et al. HLA class II alleles in Chinese patients with hepatocellular carcinoma. Liver 2001;21:143–148.
   PubMedGoogle Scholar
• Ji X, Zhang Q, Li B, et al. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Infect Genet Evol. 2014;28:201–209.
   PubMed Web of Science ®Google Scholar
• Kim LH, Cheong HS, Namgoong S, et al. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population. Infect Genet Evol. 2015;33:72–76.
   PubMed Web of Science ®Google Scholar
• Mbarek H, Ochi H, Urabe Y, et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet. 2011;20:3884–3892.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Kim HY, Lee JH, et al. A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum Mol Genet. 2013;22:4233–4238.
   PubMed Web of Science ®Google Scholar
• Al-Qahtani AA, Al-Anazi MR, Abdo AA, et al. Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients. PloS One. 2014;9:e80445.
   Google Scholar
• Hu L, Zhai X, Liu J, et al. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology. 2012;55:1426–1431.
   PubMed Web of Science ®Google Scholar
• Wang Y, Qu A, Wang H. Signal transducer and activator of transcription 4 in liver diseases. Int J Biol Sci. 2015;11:448–455.
   PubMed Web of Science ®Google Scholar
• Clark A, Gerlach F, Tong H, et al. A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma. Infect Genet Evolut. 2013;18:257–261.
   PubMed Web of Science ®Google Scholar
• Chen K, Shi W, Xin Z, et al. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population. PloS One. 2013;8:e77315
   Google Scholar
• Liao Y, Cai B, Li Y, et al. Association of HLA-DP/DQ and STAT4 polymorphisms with HBV infection outcomes and a mini meta-analysis. PloS One. 2014;9:e111677.
   Google Scholar
• Chen W, Wang M, Zhang Z, et al. Replication the association of 2q32.2-q32.3 and 14q32.11 with hepatocellular carcinoma. Gene. 2015;561:63–67.
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhu Y, Peng J, et al. STAT4 genetic polymorphisms association with spontaneous clearance of hepatitis B virus infection. Immunol Res. 2015;62:146–152.
   PubMed Web of Science ®Google Scholar
• Margalit M, Shibolet O, Klein A, et al. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes. Int J Cancer. 2005;115:443–449.
   PubMed Web of Science ®Google Scholar
• Wang G, Chen JH, Qiang Y, et al. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. World J Gastroenterol. 2015;21:3983–3993.
   PubMed Web of Science ®Google Scholar
• Bahram S. MIC genes: from genetics to biology. Adv.n Immunol. 2000;76:1–60.
   PubMed Web of Science ®Google Scholar
• Chen D, Gyllensten U. MICA polymorphism: biology and importance in cancer. Carcinogenesis. 2014;35:2633–2642.
   PubMed Web of Science ®Google Scholar
• Kumar V, Yi Lo PH, Sawai H, et al. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma. PloS One. 2012;7:e44743.
   Google Scholar
• Lange CM, Bibert S, Dufour JF, et al. Comparative genetic analyzes point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. J Hepatol. 2013;59:504–509.
   PubMed Web of Science ®Google Scholar
• Al-Qahtani AA, Al-Anazi M, Abdo AA, et al. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients. Exp Mol Pathol. 2013;95:255–258.
   PubMed Web of Science ®Google Scholar
• Tong HV, Toan NL, Song LH, et al. Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants. J Viral Hepat. 2013;20:687–698.
   PubMed Web of Science ®Google Scholar
• Yang H, Lan P, Hou Z, et al. Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma. Br J Cancer. 2015;112:112–121.
   PubMed Web of Science ®Google Scholar